Tessera Defense and Homeland Security (HLSQ) vs Silexion Therapeutics (SLXN)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 10, 2026.
Summary
Silexion Therapeutics is the larger company by market cap ($3.1 million vs $2.6 million), about 1.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | HLSQ | SLXN |
|---|---|---|
| Share price | $0.285 | $0.2146 |
| Market cap | $2.57M | $3.11M |
| 1-day change | -2.23% | -8.64% |
| EPS (TTM) | $-160.60 | $-24.86 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $122.93 | $39.40 |
| 52-week low | $0.263 | $0.2079 |
| Distance from 52-week high | -99.77% | -99.46% |
| Analyst consensus | — | none |
| Avg. price target upside | — | +2229.92% |
| Average volume | 634.79K | 10.05M |
| Shares outstanding | 9.03M | 14.47M |
| Employees | 20 | 13 |
| Sector | Health Care | Health Care |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Biotechnology: Biological Products (No Diagnostic Substances) |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
About Tessera Defense and Homeland Security
HLSQ stock →Tessera Defense and Homeland Security Inc. develops and provides defense, homeland security, and critical infrastructure technologies.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 20 employees
About Silexion Therapeutics
SLXN stock →Silexion Therapeutics Corp, a biopharmaceutical company, discovers and develops RNA interference (RNAi)-based cancer drugs and delivery systems to treat malignant solid tumors. The company engages in the treatment of solid tumors through its proprietary LODER delivery platform.
Health Care · Biotechnology: Biological Products (No Diagnostic Substances) · 13 employees
HLSQ vs SLXN FAQ
Which is bigger, Tessera Defense and Homeland Security or Silexion Therapeutics?
Silexion Therapeutics (SLXN) is larger, with a market capitalization of $3.11M compared with $2.57M for Tessera Defense and Homeland Security (HLSQ).
Are Tessera Defense and Homeland Security and Silexion Therapeutics in the same industry?
Yes. Both are classified in the Biotechnology: Biological Products (No Diagnostic Substances) industry within the Health Care sector.